• Francesco Vasques, Anna Cavazza, and William Bernal.
• Liver Intensive Therapy Unit, Institute of Liver Studies, King's College Hospital, London, UK.
• Curr Opin Crit Care. 2022 Apr 1; 28 (2): 198207198-207.

Purpose Of ReviewPresent an outline of acute liver failure, from its definition to its management in critical care, updated with findings of selected newer research.Recent FindingsSurvival of patients with acute liver failure has progressively improved. Intracranial hypertension complicating hepatic encephalopathy is now much less frequent than in the past and invasive ICP monitoring is now rarely used. Early renal replacement therapy and possibly therapeutic plasma exchange have consolidated their role in the treatment. Further evidence confirms the low incidence of bleeding in these patients despite striking abnormalities in standard tests of coagulation and new findings of abnormalities on thromboelastographic testing. Specific coagulopathy profiles including an abnormal vWF/ADAMTS13 ratio may be associated with poor outcome and increased bleeding risk. Use of N-acetylcysteine in nonparacetamol-related cases remains unsupported by robust clinical evidence. New microRNA-based prognostic markers to select patients for transplantation are described but are still far from widespread clinical applicability; imaging-based prognostication tools are also promising. The use of extracorporeal artificial liver devices in clinical practice is yet to be supported by evidence.SummaryMedical treatment of patients with acute liver failure is now associated with significantly improved survival. Better prognostication and selection for emergency liver transplant may further improve care for these patients.Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

23 keywords...

hide…